SCHEMBL3683986

SCHEMBL3683986

N=C(N)SCc1cc(CSC(=N)N)c(Br)cc1Br

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP1A1 P05023 1/20 0.65
ATP1B1 P05026 1/20 0.65
ATP1A3 P13637 1/20 0.65
ATP1B2 P14415 1/20 0.65
ATP1A2 P50993 1/20 0.65
ATP1B3 P54709 1/20 0.65
FXYD2 P54710 1/20 0.65
ATP1A4 Q13733 1/20 0.65
MAPT P10636 1/20 0.57
IDO1 P14902 9/20 0.52
NOS1 P29475 2/20 0.50
HTT P42858 5/20 0.49
CYP1A2 P05177 1/20 0.47
PRMT1 Q99873 1/20 0.47
LMNA P02545 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
TAAR1 Q96RJ0 2/20 0.47
SLC11A2 P49281 2/20 0.47
RAB9A P51151 2/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3774270 0.81 IDO1 (0.59) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL3688275 0.79 ATP1A1 (0.64) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Hydrochloric Acid SCHEMBL2810166 0.77 ATP1A1 (0.62) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL12433171 0.76 IDO1 (0.62) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL3684816 0.75 MAPT (0.74) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL22275840 0.75 SMN1; SMN2 (0.61) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Hydrochloric Acid SCHEMBL4008343 0.73 MAPT (0.71) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Bromide SCHEMBL22263116 0.73 IDO1 (0.62) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL20932350 0.72 MAPT (0.64) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL22275673 0.72 IDO1 (0.65) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 WO claimed
EP-2068855-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-06-17 EP claimed
WO-2008151288-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-12-11 WO claimed
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 WO disclosed
EP-2068855-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-06-17 EP disclosed
WO-2008151288-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-12-11 WO disclosed